FENC – fennec pharmaceuticals inc. (US:NASDAQ)
Stock Stats
News
Fennec Pharmaceuticals Announces Commercial Launch of PEDMARQSI® In Germany
Fennec Pharmaceuticals Inc (NASDAQ: FENC) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $13.00 price target on the stock.
Fennec Pharmaceuticals Announces Pedmarqsi® Positive Recommendation by NICE for the Prevention of Cisplatin-Induced Hearing Loss in England and Wales [Yahoo! Finance]
Fennec Pharmaceuticals Announces Pedmarqsi® Positive Recommendation by NICE for the Prevention of Cisplatin-Induced Hearing Loss in England and Wales
Fennec Pharmaceuticals Announces Early Partial Repayment of Its Outstanding Convertible Debt Facility with Petrichor Healthcare Capital Management [Yahoo! Finance]
Form 4 FENNEC PHARMACEUTICALS For: Feb 14 Filed by: RALLIS CHRIS A
Form 144 FENNEC PHARMACEUTICALS Filed by: RALLIS CHRIS A
Form SCHEDULE 13G/A FENNEC PHARMACEUTICALS Filed by: Solas Capital Management, LLC
Form SCHEDULE 13G/A FENNEC PHARMACEUTICALS Filed by: DG Capital Management, LLC
Form 4 FENNEC PHARMACEUTICALS For: Feb 05 Filed by: Raykov Rosty
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.